**Core Concept**
Multiple myeloma is a **malignant plasma cell disorder** characterized by the proliferation of a single clone of plasma cells in the bone marrow. This leads to an overproduction of a single type of **immunoglobulin**, resulting in various clinical manifestations. The diagnosis and management of multiple myeloma involve understanding its pathophysiology and clinical features.

**Why the Correct Answer is Right**
Since the options are not provided, let's discuss a key aspect of multiple myeloma: **bone marrow involvement**. The proliferation of malignant plasma cells in the bone marrow can lead to **anemia**, **bone lesions**, and **hypercalcemia** due to the increased activity of **osteoclasts**. The diagnosis of multiple myeloma often involves **bone marrow biopsy**, **serum protein electrophoresis**, and **urine protein electrophoresis** to detect the presence of a monoclonal protein.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's challenging to provide a detailed explanation. However, common incorrect statements about multiple myeloma might include misconceptions about its diagnosis, treatment, or clinical features.
**Option B:** Similarly, without the specific option, it's difficult to address. However, incorrect statements might relate to the role of **cytogenetic abnormalities** or the importance of **international staging system** in multiple myeloma.
**Option C:** This option might be incorrect if it misrepresents the **prognostic factors** or **treatment outcomes** in multiple myeloma.
**Option D:** This could be incorrect if it inaccurately describes the **clinical manifestations** or **complications** of multiple myeloma.

**Clinical Pearl / High-Yield Fact**
A key point to remember in multiple myeloma is the **CRAB criteria**, which include **hypercalcemia**, **renal failure**, **anemia**, and **bone lesions**. These criteria are crucial for diagnosing and managing the condition.

**Correct Answer:**